Engineered Gadolinium‐Decorated Magnetic Resonance Nanoprobes for Enhanced Liver Fibrosis Theranostics
Advanced Healthcare Materials · 2025
DOI: 10.1002/adhm.202503891 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2025. Verfasst von Yingqi Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China. Hauptthemen laut MEDLINE: Liver Cirrhosis, Gadolinium, Magnetic Resonance Imaging, Theranostic Nanomedicine. Die Arbeit nennt 34 Literaturangaben. Gefördert von: Taishan Scholar Foundation of Shandong Province, Natural Science Foundation of Shandong Province.
Abstract (Originalsprache)
Liver fibrosis has the potential to advance to irreversible cirrhosis or hepatocellular carcinoma, rendering early diagnosis and intervention of utmost importance. During liver fibrogenesis, lysyl oxidase enzymes become upregulated, which facilitate ε amino groups of lysine in extracellular matrix proteins to become oxidized, yielding the aldehyde‐containing allysine (Lys Ald ). In this context, a novel hydrazine‐functionalized gadolinium‐platinum nanoplatform (Pt@Gd 2 O 3 ‐PEG‐N 2 H 4 ) has been engineered to facilitate accurate diagnosis and therapy of liver fibrosis. The platform achieves targeted delivery to activated hepatic stellate cells (aHSCs) via hydrazine‐mediated covalent binding to Lys Ald , which is enriched in fibrotic regions of the liver. Additionally, GPPN exhibits dual enzymatic activities analogous to catalase and peroxidase, providing oxygen to mitigate hypoxia in fibrotic liver tissues and generating highly toxic hydroxyl radicals (·OH) for the selective ablation of aHSCs. There are no significant adverse effects in histological or hematological evaluations. Moreover, GPPN improves magnetic resonance imaging (MRI) signals of liver fibrosis to enable more accurate assessment of disease progression. Overall, GPPN presents considerable potential for the precise diagnosis and effective therapy of liver fibrosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.
- School of Chemistry and Pharmaceutical Engineering, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.
- School of Science, Shandong Jianzhu University, Jinan, China.
- Central Hospital Affiliated to Shandong First Medical University, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, China.
ORCID-Profile: Xiao Sun
Förderung
- Taishan Scholar Foundation of Shandong Province
- Natural Science Foundation of Shandong Province
Zitieren
APA
Wang, Y., Zhang, Q., Yan, B., Pang, L., Ren, Y., Inam, M., Zhang, M., Ni, N., Xu, X., Sun, X., & Zhou, S. (2025). Engineered Gadolinium‐Decorated Magnetic Resonance Nanoprobes for Enhanced Liver Fibrosis Theranostics. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202503891
Vancouver
Wang Y, Zhang Q, Yan B, Pang L, Ren Y, Inam M, et al. Engineered Gadolinium‐Decorated Magnetic Resonance Nanoprobes for Enhanced Liver Fibrosis Theranostics. Advanced Healthcare Materials. 2025. doi:10.1002/adhm.202503891
BibTeX
@article{Wang2025,
author = {Wang, Yingqi and Zhang, Qian and Yan, Bowen and Pang, Lihua and Ren, Yuhang and Inam, Muhammad and Zhang, Mengmeng and Ni, Nengyi and Xu, Xueli and Sun, Xiao and Zhou, Song},
title = {Engineered Gadolinium‐Decorated Magnetic Resonance Nanoprobes for Enhanced Liver Fibrosis Theranostics},
journal = {Advanced Healthcare Materials},
year = {2025},
doi = {10.1002/adhm.202503891}
}
EUVIMED